Back to Search
Start Over
Controlling the Control Arm in Metastatic Castration-Resistant Prostate Cancer Trials: Best Standard of Care or the Minimum Standard of Care?
- Source :
-
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 May 10; Vol. 40 (14), pp. 1518-1521. Date of Electronic Publication: 2022 Feb 21. - Publication Year :
- 2022
-
Abstract
- Competing Interests: Simon Van WambekeConsulting or Advisory Role: JanssenTravel, Accommodations, Expenses: Roche, Janssen-Cilag, Ipsen Francisco Emilio Vera-BadilloConsulting or Advisory Role: Bayer, AstraZeneca, Janssen OncologyResearch Funding: AstraZeneca/MedImmune (Inst) Bishal GyawaliConsulting or Advisory Role: Vivio HealthNo other potential conflicts of interest were reported.
Details
- Language :
- English
- ISSN :
- 1527-7755
- Volume :
- 40
- Issue :
- 14
- Database :
- MEDLINE
- Journal :
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 35188830
- Full Text :
- https://doi.org/10.1200/JCO.21.02304